JP2015000064A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015000064A5 JP2015000064A5 JP2014123573A JP2014123573A JP2015000064A5 JP 2015000064 A5 JP2015000064 A5 JP 2015000064A5 JP 2014123573 A JP2014123573 A JP 2014123573A JP 2014123573 A JP2014123573 A JP 2014123573A JP 2015000064 A5 JP2015000064 A5 JP 2015000064A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- hematopoietic stem
- bone marrow
- progenitor cells
- primary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/919,241 | 2013-06-17 | ||
| US13/919,241 US9428748B2 (en) | 2013-06-17 | 2013-06-17 | Method of expanding hematopoietic stem cells |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015000064A JP2015000064A (ja) | 2015-01-05 |
| JP2015000064A5 true JP2015000064A5 (enExample) | 2017-08-03 |
| JP6532653B2 JP6532653B2 (ja) | 2019-06-19 |
Family
ID=50942591
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014123573A Active JP6532653B2 (ja) | 2013-06-17 | 2014-06-16 | 造血幹細胞の増殖方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9428748B2 (enExample) |
| EP (1) | EP2816107B1 (enExample) |
| JP (1) | JP6532653B2 (enExample) |
| DK (1) | DK2816107T3 (enExample) |
| ES (1) | ES2757508T3 (enExample) |
| HU (1) | HUE046356T2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY194135A (en) | 2016-02-04 | 2022-11-14 | Zhenglun Zhu | Treatment and diagnosis of inflammatory disorders |
| GB201608944D0 (en) | 2016-05-20 | 2016-07-06 | Ospedale San Raffaele And Fond Telethon | Gene Tharapy |
| CN115803435A (zh) | 2020-05-06 | 2023-03-14 | 塞勒克提斯公司 | 用于在细胞基因组中靶向插入外源序列的方法 |
| US12534744B2 (en) | 2020-05-06 | 2026-01-27 | Cellectis S.A. | Methods to genetically modify cells for delivery of therapeutic proteins |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| JPS6147500A (ja) | 1984-08-15 | 1986-03-07 | Res Dev Corp Of Japan | キメラモノクロ−ナル抗体及びその製造法 |
| EP0173494A3 (en) | 1984-08-27 | 1987-11-25 | The Board Of Trustees Of The Leland Stanford Junior University | Chimeric receptors by dna splicing and expression |
| GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
| JPS61134325A (ja) | 1984-12-04 | 1986-06-21 | Teijin Ltd | ハイブリツド抗体遺伝子の発現方法 |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| EP0247091B1 (en) | 1985-11-01 | 1993-09-29 | Xoma Corporation | Modular assembly of antibody genes, antibodies prepared thereby and use |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US5679647A (en) | 1993-08-26 | 1997-10-21 | The Regents Of The University Of California | Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
| US5908779A (en) | 1993-12-01 | 1999-06-01 | University Of Connecticut | Targeted RNA degradation using nuclear antisense RNA |
| US5739118A (en) | 1994-04-01 | 1998-04-14 | Apollon, Inc. | Compositions and methods for delivery of genetic material |
| US5837533A (en) | 1994-09-28 | 1998-11-17 | American Home Products Corporation | Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent |
| CA2386192A1 (en) * | 1999-10-07 | 2001-04-12 | Avi Biopharma, Inc. | C-myc antisense-treated hematopoietic stem cell composition and method |
| CN1768139A (zh) * | 2003-02-10 | 2006-05-03 | 独立行政法人产业技术总合研究所 | 通过dna干扰调控基因的表达 |
| AU2004217699B2 (en) * | 2003-03-07 | 2008-07-03 | Gamida-Cell Ltd. | Expansion of renewable stem cell populations using modulators of PI 3-kinase |
| EP1991246B1 (en) | 2006-02-22 | 2013-09-11 | Zhenglun Zhu | Treatment of development-related disorders |
| MX373998B (es) * | 2006-03-24 | 2020-07-22 | Childrens Medical Center | Uso de un modulador de células madre hematopoyeticas (hsc) para promover el crecimiento de hsc. |
| ES2707590T3 (es) * | 2009-07-15 | 2019-04-04 | Zhenglun Zhu | Gestión del tratamiento de trastornos inflamatorios o autoinmunitarios usando expresión de Hom-1 |
| WO2011028819A1 (en) * | 2009-09-01 | 2011-03-10 | The Trustees Of Columbia University In The City Of New York | Synergistic transcription modules and uses thereof |
| EP2643454A4 (en) | 2010-11-24 | 2014-05-21 | Hong Gao | EXPANSION OF HEMATOPOETIC STEM CELLS |
| WO2012170979A1 (en) | 2011-06-10 | 2012-12-13 | Zhenglun Zhu | Human homeobox gene ventx and macrophage terminal differentiation and activation, compositions and methods thereof |
| JP2014531898A (ja) * | 2011-09-11 | 2014-12-04 | オーラセンス, エルエルシーAurasense, Llc | 細胞取り込み制御システム |
| EP3872169A1 (en) * | 2013-04-10 | 2021-09-01 | Zhenglun Zhu | Homeobox transcription factor ventx regulates differentiation and maturation of human dendritic cells |
-
2013
- 2013-06-17 US US13/919,241 patent/US9428748B2/en active Active
-
2014
- 2014-06-16 DK DK14172624T patent/DK2816107T3/da active
- 2014-06-16 HU HUE14172624A patent/HUE046356T2/hu unknown
- 2014-06-16 ES ES14172624T patent/ES2757508T3/es active Active
- 2014-06-16 JP JP2014123573A patent/JP6532653B2/ja active Active
- 2014-06-16 EP EP14172624.0A patent/EP2816107B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX384315B (es) | Agente para el tratamiento y/o prevención de enfermedades asociadas con anormalidades inmunes. | |
| MX2022006107A (es) | Metodos y composiciones para dosificacion en terapia celular adoptiva. | |
| PH12021551189A1 (en) | Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo | |
| BR112017014269A2 (pt) | células exterminadoras naturais e usos das mesmas | |
| MX363243B (es) | Composiciones para tratar cáncer y usos de dichas composiciones. | |
| JP2014240404A5 (enExample) | ||
| TW201613956A (en) | Novel immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL) | |
| MX2022008523A (es) | Compuestos que interactuan con glicanos y metodos de uso. | |
| NZ739448A (en) | Transgene genetic tags and methods of use | |
| MA40057A (fr) | Traitement thérapeutique de maladie cutanée au moyen de micro-organismes cutanés commensaux recombinants | |
| EP4272757A3 (en) | Modified nk-92 cells for treating cancer | |
| JP2018522041A5 (enExample) | ||
| HRP20240798T1 (hr) | Terapija matičnim stanicama kod patologija endometrija | |
| EA201790563A1 (ru) | Применение реслизумаба для лечения эозинофильной астмы со степенью тяжести от умеренной до тяжелой | |
| BR112018008931A8 (pt) | ?compostos para tratamento de distúrbios hipoproliferativos? | |
| RU2016108808A (ru) | Терапевтическое применение vegf-c и ccbe1 | |
| MD20120127A2 (en) | Recombinant Koi herpesvirus (KHV), method for its production and vaccine for the prevention of a disease caused by KHV | |
| EA201692111A1 (ru) | Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний | |
| JP2015517520A5 (enExample) | ||
| JP2016515123A5 (enExample) | ||
| CY1122042T1 (el) | Συνθεση για χρηση στη θεραπεια του πονου που σχετιζεται με μεσοσπονδυλιο δισκο | |
| JP2015044878A5 (enExample) | ||
| WO2016066722A3 (en) | Bacteriophage combinations for human or animal therapy | |
| MD20180049A2 (ro) | Compoziţie farmaceutică | |
| WO2015114633A8 (en) | Actin binding peptides and compositions comprising same for inhibiting angiogenesis and treating medical conditions associated with same |